Reader for Molecular Informatics
Co-founder of Healx Ltd.
Co-founder of PharmEnable Ltd.
- Committed to developing new life science data analysis methods (AI/ML/data science) and their application, primarily related to chemical biology, drug discovery and in silico toxicology
- Expertise comprises data ranging from chemical structure and gene expression data to phenotypic readouts and preclinical information, applied to both efficacy- and safety/tox-related questions
- Collaborating with academic research groups, as well as pharmaceutical, chemical, and consumer goods companies (Eli Lilly, AstraZeneca, GSK, BASF, Johnson&Johnson/Janssen, Unilever, ...)
- Co-founder/founding CTO and current SAB member of Healx Ltd. (data-driven drug repurposing for rare diseases, and beyond); co-founder of PharmEnable Ltd.; SAB member of Lhasa Ltd. (toxicology and metabolism prediction) and Cresset Ltd.
- Currently leading a group of ca. 15 PhD students, postdocs, project students and visitors at the Centre for Molecular Informatics at the University of Cambridge, http://www-ucc.ch.cam.ac.uk/
Publications
Sulfated Ceria Catalyzed Synthesis of Imidazopyridines and Their Implementation as DNA Minor Groove Binders.
– Chemistry & Biodiversity
(2019)
16,
e1800435
(DOI: 10.1002/cbdv.201800435)
Correction to: Concordance analysis of microarray studies identifies representative gene expression changes in Parkinson's disease: a comparison of 33 human and animal studies.
– BMC Neurol
(2019)
19,
16
(DOI: 10.1186/s12883-019-1240-7)
Prediction of UGT-mediated Metabolism Using the Manually Curated MetaQSAR Database.
– ACS Medicinal Chemistry Letters
(2019)
10,
633
Characterizing ABC-transporter substrate-likeness using a clean-slate genetic background
– Front Pharmacol
(2019)
10,
448
(DOI: 10.3389/fphar.2019.00448)
Maximizing gain in high-throughput screening using conformal prediction
– J Cheminform
(2018)
10,
7
(DOI: 10.1186/s13321-018-0260-4)
Systemic neurotransmitter responses to clinically approved and experimental neuropsychiatric drugs.
– Nature Communications
(2018)
9,
4699
(DOI: 10.1038/s41467-018-07239-1)
Erratum: Discovery of a non-toxic [1,2,4]triazolo[1,5-a]pyrimidin-7-one (WS-10) that modulates ABCB1-mediated multidrug resistance (MDR) (Bioorganic & Medicinal Chemistry (2018) 26(18) (5006–5017)(S0968089618306692)(10.1016/j.bmc.2018.08.021))
– Bioorganic and Medicinal Chemistry
(2018)
26,
5974
(DOI: 10.1016/j.bmc.2018.10.027)
Deep Confidence: A Computationally Efficient Framework for Calculating Reliable Prediction Errors for Deep Neural Networks.
– J Chem Inf Model
(2019)
59,
1269
(DOI: 10.1021/acs.jcim.8b00542)
Information-Derived Mechanistic Hypotheses for Structural Cardiotoxicity
– Chemical research in toxicology
(2018)
31,
1119
Discovery of a small-molecule inhibitor of specific serine residue BAD phosphorylation.
– Proc Natl Acad Sci U S A
(2018)
115,
E10505
(DOI: 10.1073/pnas.1804897115)
- <
- 2 of 31